Growing evidence supports that downregulation of JAK2 and STAT3 phosphorylation can mitigate inflammation, as seen in conditions such as cerebral ischemic stroke (IS) injury [30], LPS-induced microglial cell inflammation [29], atopic dermatitis [32], and rheumatoid arthritis (RA) [33]. This evidence concerns the gene STAT3 and rheumatoid arthritis.